Beranda › Penyakit Alzheimer › Rhode Island
Uji klinis Penyakit Alzheimer di Rhode Island
8 studi untuk Penyakit Alzheimer mencari peserta di lokasi di Rhode Island.
Kota di Rhode Island
Teks studi resmi (Bahasa Inggris)
Dominantly Inherited Alzheimer Network (DIAN)
- Butler Hospital, Providence
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT00869817A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Alzheimer's Disease and Memory Disorders Center at Rhode Island Hospital, Providence
Menerima pesertaFase 3
Usia 55 hingga 90 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06585787Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Butler Hospital, Providence
Menerima pesertaFase 3
Usia 50 hingga 90 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07177352Alzheimer's Tau Platform: Master Protocol
- Butler Hospital Memory and Aging Program, Providence
Menerima pesertaFase 2
Usia 50 hingga 80 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06957418A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Rhode Island Mood & Memory Research Institute, East Providence
Menerima pesertaFase 3
Usia 60 hingga 85 · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT06976216A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Butler Hospital, Providence
Menerima pesertaFase 2/3Sukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT06647498A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Butler Hospital, Providence
Menerima pesertaFase 2/3Sukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT05552157Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
- K2 Medical Research, East Providence
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 60 hingga 90 · Semua jenis kelamin · Diperbarui 15 Apr 2026 · NCT06584357Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.